What’s Behind Thursday's Stock Moves for Palantir, Pfizer, and Others?

2 min read | October 10, 2024 03:46 PM EDT | By Team Kalkine Media

What’s Behind Thursday's Stock Moves for Palantir, Pfizer, and Others? — Image source: Shutterstock

Pharmaceutical Sector

Pfizer (NEO:PFE) operates within the pharmaceutical sector, and its stock price saw a recent rise, following the announcement of a quarterly dividend. The company’s dividend reflects its ongoing commitment to shareholders. However, Pfizer faces headwinds in its RSV vaccine program. Regulatory authorities in the U.S. have reduced the target age range for the vaccine, and reports suggest that only a single dose may be necessary. These changes could influence the company's standing in the vaccine market.

In this sector, Moderna (MRNA) and Novavax (NVAX) continue to be prominent names, particularly in vaccine development. Roche (RHHBY), another significant pharmaceutical firm, has expanded its focus beyond diagnostics, working on an innovative obesity drug. However, potential side effects, such as gastrointestinal issues and elevated heart rates, could pose challenges for its widespread adoption.

Technology Sector

Broadcom has shown considerable momentum in the technology sector. After a brief decline following its earnings report, the stock has rebounded and reached new highs. This recovery highlights the company's resilience and strong positioning within the sector.

In the cybersecurity space, Fortinet (FTNT) has also performed well, closing above a key threshold. The company remains a major player in the cybersecurity industry, with consistent stock movement reflecting investor confidence. Crowdstrike Holdings (CRWD), which has been recovering from earlier lows, continues its upward trend, signaling strength in the cybersecurity market.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Incorporated (Kalkine Media), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.